|Bid||0.00 x 1000|
|Ask||0.00 x 900|
|Day's Range||22.50 - 24.22|
|52 Week Range||12.95 - 56.50|
|Beta (5Y Monthly)||2.17|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jun 01, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Canopy Growth, the largest marijuana stock, has fallen after a post-election rally. And Canada is still dealing with coronavirus-related lockdowns. Is CGC stock a buy right now?
Canadian marijuana stocks have fallen from their February highs. But one player in the industry got a lot bigger after a merger deal.
MindMed’s Nasdaq debut Tuesday made it the second psychedelic drug developer to be listed on a major U.S. stock exchange.